Abstract Book
Dear Colleagues,
It is with great pleasure that I welcome you to the 62nd National Congress of the Italian Society of Rheumatology, which is once again being held in the familiar setting of the Rimini Conference Centre, a place that has become symbolic for our scientific community.
The Congress is an essential event for all of us, not only for professional development, but also for discussion, collective growth and strengthening the bonds within our society. This year, the Congress has once again been accredited by the ECM (Italian Continuing Medical Education) to allow for even wider participation and to meet the needs of all colleagues.
The programme for this edition has been designed to offer a dynamic journey, rich in innovative content, open to interdisciplinary dialogue and future challenges.
This year marks the 75th anniversary of the founding of the SIR, and to mark the occasion, we will be organising an opening ceremony that will include a session dedicated to the evolution of rheumatology: from its historical roots to new perspectives linked to artificial intelligence, with two highly knowledgeable speakers capable of conveying passion and enthusiasm.
In addition to the plenary sessions and institutional symposia, we are also confirming the formulas that have been so successful over the years: the Hands On courses, the “Meet the Expert” sessions, the “Question Time” sessions and the traditional Review Course on Saturday morning, which will offer participants the opportunity to update themselves on topics of great practical impact.
Ample space will also be reserved for oral presentations (including those in English) and poster displays, where we will have the opportunity to take stock of the research activities of national groups. As every year, we will reward the authors of the best presentations. We are also renewing the “Verso EULAR” initiative, which highlights the contribution of our young scientific community.
Our colleagues from SIRyoung will once again be protagonists this year, with a space dedicated to them, demonstrating our ongoing commitment to the younger generation.
There will also be activities for health professionals, coordinated by For-Rheuma, and meetings with patient associations, key partners in the treatment process and in dialogue with institutions.
Once again this year, we will have our usual convivial and sporting event with the SIR RUN. After the great success of last year's edition, on Wednesday evening, running enthusiasts will be able to try their hand at two routes, 5 and 10 km, or a 5 km walking route.
As always, the success of this Congress depends on the quality of each of your contributions. I am confident that this edition will once again offer valuable insights, strengthening our sense of belonging to a vibrant, authoritative and constantly evolving Society.
In this spirit, and on behalf of the entire Executive Committee, I wish you stimulating days, rich in content and fruitful professional and personal relationships.
Enjoy the Congress!
All Items
-
CO:08:5 | Clinical impact of anti-Ro52 antibodies in idiopathic inflammatory myopathies: insights from a multicenter Italian cohort Paola Bizioli1, Cesare Tomasi2, Francesca Bellisai3, Francesca Buzzulini4, Antonio Tonutti5|6, Angela Ceribelli5|6, Edoardo Conticini3, Anna Ghirardello7, Luca Iaccarino7, Danilo Villalta4, Franco Franceschini1, Ilaria Cavazzana1. | 1Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili of Brescia; 2Department of Clinical and Experimental Sciences, University of Brescia; 3Department of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena; 4Department of Laboratory Immunology and Allergology, Santa Maria degli Angeli Hospital, Pordenone; 5Department of Biomedical Sciences, Humanitas University, Rozzano (MI); 6Rheumatology and Clinical Immunology, Istituti di Ricovero e Cura a Carattere Scientifico, Humanitas Research Hospital, Rozzano (MI); 7Division of Rheumatology, Department of Medical and Surgical Sciences, University of Padova, Italy
255 -
PO:07:095 | Clinical impact of therapeutic modification following changes in AIFA reimbursement criteria for JAK inhibitors in patients with RA in remission/low disease activity: analysis of the multicenter JAK-SWAP RER study in Emilia-Romagna Marta Raschella1, Giulia Furia1, Martina Di Nunzio1, Francesco Luca Renzullo2, Francesco Girelli2, Federica Pignatti3, Francesco Ursini3, Licia Vultaggio4, Pierluigi Cataleta4, Elena Bravi5, Eugenio Arrigoni5, Francesca Bergossi6, Enrica Vandelli7, Massimo Reta6|7, Viola Magnani8, Andreina Manfredi8|9, Giuseppe Germanò8, Alessandra Bortoluzzi1, Marcello Govoni1, Ettore Silvagni1 | 1Unità Operativa Complessa di Reumatologia, Dipartimento di Scienze Mediche, Università degli Studi di Ferrara e Azienda Ferrara; 2UOS Reumatologia, Ospedale GB Morgagni, Forlì; 3UOC Reumatologia, Istituto ortopedico Rizzoli, Bologna; 4UO Reumatologia, AUSL Romagna Ospedale di Ravenna; 5UO Reumatologia, Azienda USL di Piacenza; 6Reumatologia Osp. Maggiore, Bologna; 7UO Medicina Interna ad Indirizzo Reumatologico Interaziendale SC AUSL Bologna, IRCCS Policlinico di SantOrsola, Bologna; 8U.O Reumatologia, Santa Maria Nuova di Reggio Emilia; 9Università degli studi di Modena e Reggio Emilia, Italy
247 -
PO:21:019 | Clinical phenotypes in IgG4-related disease: ACR/EULAR classification and practical limitations Mattia Caliste1, Flavia D'Auria2, Linda Mastromanno1, Francesca Carfora2, Carla Giordano3, Cristiano Alessandri1, Marcella Visentini2, Fabrizio Conti1, Roberta Priori1|4 | 1Dipartimento Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma; 2Dipartimento Medicina Traslazionale e di Precisione, Sapienza Università di Roma; 3Dipartimento Scienze Radiologiche, Oncologiche e Anatomo-patologiche, Sapienza Università di Roma; 4Saint Camillus International University of Health Science, UniCamillus, Roma, Italy
228 -
CO:10:3 | Clinical response to JAK inhibitors or non-TNFi-targeted biologicals according to synovial tissue characteristics in patients with difficult-to-treat rheumatoid arthritis Mariangela Salvato1, Alessandro Giollo1, Francesca Frizzera1, Kiren Khalid1, Lorenzo Di Luozzo1, Maria Capita1, Marianna Tamussin1, Carlo Garaffoni2, Marny Fedrigo3, Annalisa Angelini3, Ettore Silvagni2, Andrea Doria1. | 1Rheumatology Unit, Department of Medicine - DIMED, University of Padova; 2Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliero-Universitaria S. Anna; 3Cardiovascular Pathology, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Italy
276 -
PO:12:186 | Clinical, functional, and microvascular features in the early diagnosis and management of pulmonary hypertension in systemic sclerosis: the importance of multimodal screening strategies Irene Carlino1, Stefania Bisogno1, Alberto Palazzuoli2, Luigi Gennari1 | 1U.O.C. Reumatologia, Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze, Università di Siena, A.O.U. Senese; 2Azienda Sanitaria Locale, Novara, Italy
236 -
PO:36:238 | Clinical, functional, and radiological similarities between interstitial lung disease–anti–myeloperoxidase and idiopathic pulmonary fibrosis Enrico Colombo1, Jessica Gozzi2, Paolo Francia3, Giulia Cervi2, Marilena Frigato1, Martina Garuti2, Francesca Bartoli1, Irene Gavioli1, Caterina Cerbone2, Massimiliano Beccaria2, Maria Teresa Costantino1 | 1SC Allergologia, Immunologia Clinica e Reumatologia, ASST Mantova; 2SC Pneumologia, ASST Mantova; 3SC Radiologia, ASST Mantova, Italy
232 -
PO:38:278 | Cognitive behavioural therapy vs. physical therapy for chronic primary low back pain: a systematic review with meta-analysis of randomised controlled trials Luca Castioni1, Stefano Salvioli2 | 1Università degli studi di Ferrara; 2Scuola di fisioterapia Claudiana, Bolzano, Italy
267 -
S02:5 | Combined anti-IL-5/IL-5r and dupilumab therapy in eosinophilic granulomatosis with polyangiitis: a European retrospective study Miriam Guerini1, Pavel Novikov2, Roberto Padoan3, Georgina Espigol Frigolé4, Jan Willem Cohen Tervaert5, Vincent Grobost6, Laurent Guilleminault7, Jan Walter Schroeder8, Bernhard Hellmich9, Joana Martins Martinho10, Camillo Ribi11, Matthieu Groh12, Benjamin Terrier13. | 1IRCCS Policlinico S. Matteo, University of Pavia, Pavia, Italy; 2Sechenov University, Moscow, Russia; 3University of Padova, Padova, Italy; 4Hospital Clinic, University of Barcelona, Barcelona, Spain; 5University of Alberta, Edmonton, Canada; 6CHU Estaing Clermont-Ferrand France; 7Toulouse University Toulouse France; 8ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy; 9Medius Kliniken Kirchheim-Teck Germany; 10ULS Santa Maria, Lisbon, Portugal; 11Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 12Hopital Foch, Suresnes, France; 13Service de Medecine interne, Hopital Cochin, AP-HP, Paris, France.
314 -
CO:10:2 | Common variable immunodeficiency patients complicated by autoimmune and inflammatory rheumatic manifestations reveal high frequency of genetic variants potentially linked to inborn errors of immunity Paolo Semeraro1, Micol Frassi1, Silvia Clara Giliani2, Franco Franceschini1, Paolo Airò1. | 1Rheumatology and Clinical Immunology Unit, ERN ReCONNET, ASST Spedali Civili of Brescia and University of Brescia; 2Medical Genetic Laboratory, ASST Spedali Civili of Brescia and University of Brescia, Italy
1026 -
PO:09:139 | Comparative evaluation of GPT-4.0, Claude 4, and MedGEMMA in automatic Kellgren-Lawrence grading of knee osteoarthritis Teresa Caferri1, Vincenzo Venerito1, Angela Carenza1, Daniele Catamerò1, Daniele Domanico1, Sergio Del Vescovo1, Lucia Cristiana Colaprico1, Lavista Marlea1, Maria Giannotta1, Giuseppe Lopalco1, Florenzo Iannone1. | 1Rheumatology Unit, Department of Precision and Regenerative Medicine and Jonian Area, University of Bari, Bari, Italy.
278 -
CO:03:3 | Contribution of mitochondrial DNA to the onset and maintenance of inflammation in Systemic Sclerosis patients Martina Orlandi1, Giorgia Sinigaglia2, Amelia Spinella1, Isabella Martusciello2, Marco De Pinto1, Giorgia Roveta1, Luca Keller1, Marcello Pinti2, Dilia Giuggioli1 | 1Dipartimento di scienze mediche e chirurgiche dei bambini e degli adulti, Università di Modena e Reggio Emilia, Italy; 2Università degli Studi di Modena e Reggio Emilia, Italy
113 -
PO:20:010 | Coordinated outpatient pathway for osteoporosis: a new organizational model for osteoporosis management Domenico Birra1, Ornella Romano2, Vincenza Sara Suppa2, Mariavittoria Guerra1, Carmine Fierarossa1, Benedetta Tartaglia1, Antonietta De Sena1, Fabio Granato Corigliano1, Serena Ippolito2, Vincenzo Nuzzo1 | 1UOC Medicina Generale, P.O. Ospedale del Mare, Asl Napoli 1 Centro; 2U.O.S.D. Malattie Endocrine del ricambio e della nutrizione, P.O. Ospedale del Mare, Asl Napoli 1 Centro, Italy
232 -
PO:08:121 | Correlation between SENS score and perceived disability in a monocentric cohort of patients affected by rheumatoid arthritis: preliminary analysis of 209 patients Francesco Angius1, Nicoleta Anamari Costin1, Mattia Fadda1, Davide Corradini2, Mattia Congia2, Elisabetta Chessa2, Alberto Floris1, Matteo Piga1 -2, Alberto Cauli1 -2 | 1SC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università di Cagliari; 2SC Reumatologia, AOU Cagliari, Italy
183 -
PO:06:082 | Correlation between ultrasonographic parameters and the Krenn synovitis score in patients with chronic infiammatory arthropathy undergoing ultrasound-guided synovial biopsy: a prospective cohort study Maria Capita1, Carlo Garaffoni1, Marianna Tamussin1, Serena Ceccato1, Giovanni Lanza2, Alessandra Bortoluzzi1, Marcello Govoni1, Ettore Silvagni1 | 1Unità di Reumatologia, Azienda Ospedaliero - Universitaria S. Anna, Cona (FE); 2Anatomia Patologica, Dipartimento di Medicina Traslazionale Università di Ferrara, Cona (FE), Italy
204 -
PO:38:285 | Cross-sectional analysis: interpretation of nonstatistically significant results in randomised controlled clinical trials in rehabilitation Caterina Mugnai1, Luca Falsiroli Maistrello2|3|4, Giacomo Fiacca3, Michele Perrucchini3, Noemi Corbetta3, Federico Amateis3, Stefano Salvioli3 | 1University of Ferrara; 2ULSS 9 Scaligera, Department of Physical Medicine and Rehabilitation, G. Fracastoro Hospital, San Bonifacio VR; 3Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa; 4School of Physiotherapy, Department of Neuroscience, Biomedicine and Movement, University of Verona, Italy
184 -
PO:35:221 | Cryofibrinogen: a cold case. Characteristics and clinical outcomes from a cryofibrinogen positive cohort Daniele Catameró1, Andrea Cito1, Cristiana Colaprico1, Teresa Caferri1, Teresa Troiano1, Anna Marinaccio1, Marco Fornaro1, Giuseppe Lopalco1, Florenzo Iannone1. | 1Unit of Rheumatology , Department of Precision and Regenerative Medicine, Area Jonica DiMePRe-J, University of Bari, Bari, Italy.
212 -
CO:06:2 | Deep immunophenotyping in patients with juvenile localized scleroderma reveals two distinct immunological endophenotypes Emiliano Marasco1, Angela Aquilani1, Rebecca Nicolai1, Ivan Caiello1, Fabrizio De Benedetti1. | 1Unità di Reumatologia, Ospdeale Pediatrico Bambino Gesù, Roma, Italy
298 -
PO:32:185 | Deep-learning analysis of high-resolution computed tomography images predicts progression and mortality in systemic sclerosis related interstitial lung disease Valentina Boni1, Rosa D'Abronzo2, Piergiacomo Cerasuolo1, Lucio Calandriello2, Giuseppe Cicchetti2, Gerlando Natalello1, Bruno Iovene5, Francesco Varone5, Giacomo Sgalla5, Luca Richeldi5, Anna Rita Larici2|4, Maria Antonietta D'Agostino1|3, Silvia Laura Bosello1|3, Enrico De Lorenzis1. | 1Division of Rheumatology and Clinical Immunology Catholic Univeristy of the Sacred Heart, Rome, Italy; 2Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Diagnostic Imaging Area, Catholic University, Rome, Italy; 3Department of Geriatric and Orthopaedic Sciences, Catholic Univeristy of the Sacred Heart, Rome, Italy; 4Department of Radiological and Hematological Sciences, Section of Radiology, Catholic Univeristy of the Sacred Heart, Rome, Italy; 5Division of Pulmonary Medicine, Catholic University of the Sacred Heart, Roma, Italy.
205 -
PO:27:108 | Delphi consensus on the shared management of patients with rheumatologic and oncologic diseases Luigi De Marco1, Augusta Ortolan2, Antonio Carletto3, Fulvia Ceccarelli4, Lorenzo Dagna5, Ginevra De Marchi6, Ennio Giulio Favalli7, Alessandro Inno8, Giuseppe Lopalco9, Francesco Ciccia10, Ennio Lubrano11, Luca Quartuccio12, Immacolata Prevete13, Roberta Ramonda14, Nicola Silvestris15, Marcello Tiseo16, Michelina Turri1, Maria Sole Chimenti1 | 1Reumatologia, allergologia e immunologia clinica, dipartimento di medicina dei sistemi, Università di Roma Tor Vergata; 2UOC Reumatologia e immunologia clinica, Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Roma; 3Unità di Reumatologia, Dipartimento di medicina, AOUI università di Verona; 4Reumatologia, Dipartimento di Scienze Cliniche, Anestesiologiche Internistiche e Cardiovascolari, Sapienza Università di Roma; 5Unità di Immunologia, Reumatologia, Allergologia e malattie rare UnIRar, IRCSS San Raffaele, Milano; 6Unità di Reumatologia, Dipartimento di medicina, Azienda Sanitaria Universitaria Integrata, Università di Udine; 7Dipartimento di Reumatologia e scienze mediche, Istituto Gaetano Pini, Università di Milano; 8Oncologia Medica, IRCCS Ospedale Sacro Cuore Don Calabria, Negrar di Valpolicella (VR); 9UOC Reumatologia, Dipartimento di Medicina di Precisione e Rigenerativa e Area Ionica, Università di Bari "Aldo Moro"; 10Unità di Reumatologia, Dipartimento di Medicina di Precisione, Università della Campania L. Vanvitelli, Napoli; 11Unità di Reumatologia, Università degli Studi del Molise, Campobasso; 12SOC Clinica Reumatologica - ASUFC, Dipartimento di Medicina, Università degli Studi di Udine; 13UOC Reumatologia Azienda Ospedaliera San Camillo-Forlanini, Roma; 14UOC di Reumatologia, Dipartimento di Medicina DIMED, Azienda Ospedale Università di Padova; 15UOC Oncologia Medica e Dipartimento Area Medica - IRCCS Istituto Tumori Giovanni Paolo II, Bari; 16UOC di Oncologia Medica, Azienda Ospedaliero-Universitaria di Parma, Italy
219 -
PO:11:175 | Dermatomyositis and immunosuppressant treatment: a case of Staphylococcus aureus pneumonia in a hospitalized patient Simona Fichera1, Andrea Cito1, Martina Vigilia1, Maria Morrone1, Teresa Caferri1, Crescenzio Scioscia1, Simone Perniola1, Giuseppe Lopalco1, Florenzo Iannone1. | 1Unit of Rheumatology, Department of Precision and Regenerative Medicine, Area Jonica, University of Bari, Bari, Italy.
279 -
PO:02:024 | Development of anti-drug antibodies in patients with peripheral and/or axial spondyloarthritis treated with infliximab or adalimumab: a monocentric cross-sectional study Gabriele Amati1, Gilda Sandri1|2, Alessandra Melegari3, Benedetta Bongiovanni1|2, Giovanni Ciancio2, Martina Orlandi1|2, Ottavio Secchi1, Dilia Giuggioli1|2 | 1Struttura complessa di Reumatologia, Azienda Ospedaliero-Universitaria Policlinico di Modena; 2Cattedra di Reumatologia, Università degli studi di Modena e Reggio Emilia; 3Dipartimento di medicina di laboratorio, Ospedale di Baggiovara, AUSL di Modena, Italy
264 -
PO:16:231 | Differential clinical features of systemic lupus erythematosus patients on biological therapies: insights from a monocentric cohort Pietro Francesco Pilo, Elisa Bellis, Claudia Garulli, Claudio Cruciani, Marta Saracco, Claudia Lomater, Elena Marucco, Gloria Crepaldi, Valeria Data, Annamaria Iagnocco, Mariele Gatto. | Academic Rheumatology Centre, Department of Clinical and Biological Sciences, University of Turin, AO Mauriziano, Torino, Italy.
228 -
PO:01:014 | Differential inflammatory responses of CD14+ and CD14– synoviocytes in psoriatic arthritis: implications for pathogenesis and targeted therapies Monia Maccaferri1, Monica Montanari2, Francesco Zambianchi3|4, Carlo Salvarani1|5, Elisa Pignatti1|4 | 1Dipartimento CHIMOMO; 2Dipartimento di Scienze e Vita; 3Dipartimento SMECHIMAI Università di Modena e Reggio Emilia; 4Azienda Ospedaliero Universitaria di Modena; 5Struttura Complessa di Reumatologia, Azienda Unità Sanitaria Locale di Reggio Emilia-IRCCS, Italy
219 -
PO:02:017 | Difficult-to-treat psoriatic arthritis: clinical and ultrasonographic predictors in a real-life cohort Federico Favaro1, Elisa Bellis1, Claudio Cruciani1, Gloria Crepaldi1, Valeria Data1, Claudia Garulli1, Claudia Lomater1, Elena Marucco1, Marta Saracco1, Mariele Gatto1, Annamaria Iagnocco1. | 1Academic Rheumatology Centre, Departement of Clinical and Biological Sciences, University of Turin, AO Mauriziano, Torino, Italy.
209 -
CO:03:1 | Distinct breath metabolomic signature in systemic sclerosis patients with pulmonary arterial hypertension Martina Iacubino1, Lorenzo Rocco1, Marco Vicenzi2|3, Chiara Bellocchi2|4, Marta Mozzo4, Adriana Severino3, Monica Caronni3, Alessandro Santaniello3, Gaia Montanelli3, Barbara Vigone3, Liam Grimmett5, Matthew Kerr5, Lorenzo Beretta3. | 1Scuola di specializzazione in Allergologia e Immunologia clinica, Università degli Studi di Milano; 2Dipartimento di Scienze Cliniche e Salute di Comunità, Dipartimento di Eccellenza 2023-2027, Università degli Studi di Milano; 3Dipartimento di Malattie Cardio-Toraciche-Vascolari, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano; 4Dipartimento di Immunologia Clinica e Medicina Interna, Scleroderma Unit - Fondazione IRCCS Ca' Granda Ospedale Maggiore, Milano, Italy; 5Owlstone Medical, Cambridge, UK
310 -
CO:07:3 | Does articular and entheseal structural damage drive pain and patient-driven reported outcomes in difficult-to-treat psoriatic arthrtis patients? Results from a cross-sectional study Fabio Massimo Perrotta1, Alen Zabotti2, Mauro Fatica1, Nicola Cabas2, Andrea Guiotto2, Nicoletta Franzolini3, Giovanni Striani2, Maria De Martino4, Cristina De Nicola5, Miriam Isola4, Andrea Di Matteo6, Gabriele De Marco6, Denis McGonagle6, Ennio Lubrano1, Luca Quartuccio4. | 1Università degli studi del Molise, Campobasso; 2University Hospital Santa Maria della Misericordia, Udine; 3Presidio Ospedaliero S. Antonio, San Daniele del Friuli (UD); 4University of Udine; 5Epidemiology Unit, Italian Society for Rheumatology, Milano, Italy; 6University of Leeds, Leeds, UK
249 -
PO:12:178 | Don't count your chickens before they hatch! Analysis of cardiovascular definitions in studies on rheumatic diseases: a systematic literature review Laura Pezzoni1, Silvia Sirotti1|2, Georgios Filippou1|2, Piercarlo Sarzi Puttini1|2, Greta Pellegrino1|2. | 1Università degli Studi di Milano, Milano; 2IRCCS Ospedale Galeazzi Sant'Ambrogio, Milano, Italy.
215 -
PO:10:146 | Dorsal myelopathy in a patient with radiographic axial spondyloarthritis Chiara Nobili1, Siria Ripiccini1, Marco Panetta1, Elisabetta Greco1, Barbara Kroegler1, Paola Conigliaro1, Alberto Bergamini1, Maria Sole Chimenti1 | 1Università degli Studi di Roma-Tor Vergata, Italy
178 -
PO:11:162 | DRESS syndrome: a case treated with mepolizumab Alessandro Belotti Masserini1, Stefania Bertocchi1, Eleonora Bruschi1, Silvia Breda1, Valeria Rossi1, Elide Lupi1, Tania Ubiali1, Fabrizio Angeli1, Massimiliano Limonta1 | 1ASST Papa Giovanni XXIII, Bergamo, Italy
333 -
PO:36:243 | Drug survival, discontinuation reasons and disease activity in patients with Behçet's disease treated with infliximab - a real-life study Antonello Sulis1, Federica Di Cianni1, Maria Laura Manca2, Rosaria Talarico1, Marta Mosca1. | 1Rheumatology Unit of Pisa, University of Pisa, Pisa, Italy, Pisa, Italy; 2Department of Clinical and Experimental Medicine and Department of Mathematics, University of Pisa, Italy, Pisa, Italy.
265 -
PO:06:092 | Early achievement of remission confers better outcomes than low disease activity in both seropositive and seronegative patients with new-onset rheumatoid arthritis Clelia Zampaglione1|2, Ludovico De Stefano1|2, Federica Sabatelli1|2, Alessio D'Isanto1|2, Blerina Xoxi1|2, Antonio Manzo1|2, Carlomaurizio Montecucco1|2, Serena Bugatti1|2. | 1Department of Internal Medicine and Therapeutics, University of Pavia, Pavia; 2Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.
229 -
PO:36:244 | Early diagnosis in eosinophilic granulomatosis with polyangiitis: a multidisciplinary approach Federico Giuseppe Lazzaro1, Elena Chiaradia2, Chiara Lombardi2, Flavia Leone1, Massimo Nucci2, Roberta Masnata2, Flora Niedda2, Maria Rita Gigante1, Pietro Rubortone1, Silvia Laura Bosello1|2, Maria Antonietta D'Agostino1|2, Augusta Ortolan1|2. | 1Divisione di Reumatologia ed Immunologia Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; 2Università Cattolica del Sacro Cuore, Roma, Italy.
210 -
PO:36:246 | Early real-world outcomes with benralizumab in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective Richard Borrelli1, Stefania Nicola1, Federica Corradi1, Iuliana Badiu1, Marzia Boem1, Valentina Marmora1, Simone Negrini1, Luisa Brussino1. | 1SCDU Immunologia e Allergologia, AO Mauriziano, Dipartimento di Scienze Mediche, Università degli Studi di Torino, Torino, Italy.
260 -
PO:12:180 | Echocardiographic screening of pulmonary hypertension in a multidisciplinary cohort of patients with interstitial lung disease Lorenzo Mattia Bianchessi1, Veronica Piccin1, Federica Sabatelli1, Lorenzo Cavagna1, Giovanni Zanframundo1, Domenicafederica Briganti2, Mauro Acquaro3, Stefano Ghio3, Domenico Sorace1, Valentina Vertui2, Ilaria Giana2, Andrea Patanè3, Veronica Codullo1 | 1UOC Reumatologia, Fondazione IRCCS Policlinico S. Matteo, Pavia; 2Centro Trapianti, Fondazione IRCCS Policlinico San Matteo, Pavia; 3UOC Cardiologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
236 -
PO:26:095 | Educational online webinars of European Reference Network on rare and complex connective tissue and musculoskeletal diseases for patients, caregivers and healthcare professionals: six years' experience Emanuele Gotelli1|2, Rosanna Campitiello1|3, Eric Hachulla4|5|6, Vanessa Smith7|8|9, Joao Eurico Fonseca10|11, Tadej Avcin12|13, Gabriele Simonini14|15, Silvia Aguilera16, Lisa Matthews17, Charissa Frank18, Wiebke Lautré19, Monica Testoni20, Diana Marinello20, Rosaria Talarico20, Marta Mosca20, Maurizio Cutolo1|2. | 1Department of Internal Medicine and Specialties, University of Genova, Genova, Italy; 2IRCCS Ospedale Policlinico San Martino, Genova, Italy; 3Department of Experimental Medicine DIMES, University of Genova, Genova, Italy; 4Institute for Translational Research in Inflammation INFINITE, Université de Lille, Lille, France; 5INSERM, Lille, France; 6Centre de référence des maladies autoimmunes systemiques rares du Nord et Nord-Ouest de France CeRAINO, Lille, France; 7Department of Internal Medicine, University of Ghent, Ghent University Hospital, Ghent, Belgium; 8Department of Rheumatology, University of Ghent, Ghent University Hospital, Ghent, Belgium; 9Unit for Molecular Immunology and Inflammation, Flemish Institute for Biotechnology, Inflammation Research Center, Ghent, Belgium; 10Centro Hospitalar Universitário Lisboa Norte EPE, Serviço de Reumatologia e Doenças Ósseas Metabólicas Lisboa Portugal; 11Universidade de Lisboa, Unidade de Investigação em Reumatologia, Instituto de Medicina Molecular João Lobo Antunes Lisboa Portugal; 12University Children Hospital, University Medical Center Ljubljana, Ljubljana, Slovenia; 13University of Ljubljana, Department of Paediatrics, Ljubljana, Slovenia; 14University of Florence, NEUROFARBA Department, Firenze, Italy; 15Meyer Children Hospital IRCCS, Rheumatology Unit, Firenze, Italy; 16Spanish Association for Antiphospholipid Syndrome, Elche, Spain; 17Relapsing Polychondritis Awareness and Support, Worcester, United Kingdom; 18Flemish Association for Hereditary Connective Tissue Disorders, Koersel, Belgium; 19CHU Bordeaux Pellegrin, Centre de Références Maladies Auto-Immunes Systémiques Rares, Bordeaux, France; 20Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.
231 -
CO:09:3 | Effectiveness and safety of nintedanib in autoimmune systemic diseases: real life data from an Italian multicentre study (Island group) of the Italian Society of Rheumatology Corrado Campochiaro1, Paola Conigliaro2, Gianluca Sambataro3, Marco Matucci-Cerinic1, Marco Sebastiani4, Gianluca Bajocchi5, Angelo Fassio6, Elena Treppo7, Elisabetta Zanatta8, Elena Bartolini9, Francesco Ferro10, Chiara Bazzini11, Nicoletta Del Papa12, Gemma Lepri13, Andrea Lo Monaco14, Marta Favero15, Annamaria Iuliano16, Francesca Li Gobbi17, Maria Sole Chimenti2, Giuseppe Muscato18, Giacomo De Luca1, Francesca Cozzini4, Lucia Dardani5, Francesco Pollastri6, Alessandro Gattron7, Beatrice Moccaldi8, Caterina Antonini9, Gaetano La Rocca10, Ilaria Cavazzana11, Andreina Manfredi5|19. | 1IRCCS San Raffaele Hospital, Vita-Salute San Raffaele, Milano; 2U.O.C. Reumatologia Dipartimento di Medicina dei Sistemi Università di Roma-Tor Vergata, Roma; 3Università Kore, Enna; 4University of Parma, Azienda Ospedaliera di Piacenza; 5UOC Reumatologia, AUSL IRCCS Reggio Emilia; 6UOC Reumatologia Università degli Studi di Verona; 7Dipartimento di Medicina, Clinica di Reumatologia, Università degli Studi di Udine; 8UOC Reumatologia, Dipartimento di Medicina DIMED, Azienda Ospedale Università di Padova; 9SC Interaziendale di Reumatologia, Dipartimento di Medicina e Chirurgia, Università di Perugia, Azienda Integrata Università; 10Dipartimento di Medicina Clinica e Sperimentale UO Reumatologia-Universitaria AOU Pisa; 11U.O. Reumatologia e Immunologia Clinica ASST Spedali Civili di Brescia; 12Clinica Reumatologica, Milano; 13S.O.D. di Reumatologia AOU Careggi, Firenze; 14UOC Reumatologia Azienda Ospedaliero-Universitaria Sant'Anna, Ferrara; 15Internal Medicine I, Department of Medicine, Ca' Foncello Hospital, AULSS2 Marca Trevigiana, Treviso; 16UOC Reumatologia, AO San Camillo Forlanini, Roma; 17Rheumatology Unit, S.Giovanni di Dio Hospital, Firenze; 18Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Disease, Policlinico, Catania; 19Università degli Studi di Modena e Reggio Emilia, Italy
249 -
PO:17:250 | Effectiveness and safety of the recombinant zoster vaccine in patients ≥18 years of age with systemic lupus Giulia Boschi1, Sheryl A. Kluberg2, Sophie E. Mayer2, O'Mareen Spence3, Driss Oraichi3, Harry Seifert3, Omar Ali3, Huifeng Yun3, Andrew L. Simon4, Jenice S. Ko4, Caroline Hugh4, Meg Her4, Kathleen Shattuck4, Richard Platt2, Aziza Jamal-Allial5, Djeneba Audrey Djibo6, Kimberly Daniels5, Qianli Ma7, Cheryl N. Mcmahill-Walraven6, Rachel P. Ogilvie8, Kristin Palmsten9, Mano Selvan7, Najat Ziyadeh8, Alexis Ogdie10, Michael George10 | 1GSK Verona Italy; 2Harvard Medical School and the Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston; 3GSK Rockville; 4Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston; 5Carelon Research, Wilmington; 6CVS Health, Blue Bell; 7Humana Healthcare Research, Louisville; 8OptumInsight Life Sciences, Boston; 9HealthPartners Institute, Bloomington; 10University of Pennsylvania, Philadelphia, USA
214 -
PO:28:126 | Effectiveness of the new AMEL system in the treatment of simple painful shoulder syndrome Antonietta Albanese1, Emilio Battisti1, Federico Filippi2 | 1Dipartimento SFTA, Università di Siena, Siena; 2Sanimed, Fisiomed, Vicenza, Italy
281 -
CO:02:2 | Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis: real world data from an Italian National Registry Valerio Fiorilli1, Francesca Romana Spinelli1, Florenzo Iannone2, Chiara Bazzani3, Alberto Cauli4, Rosario Foti5, Marcello Govoni6, Francesco Paolo Cantatore7, Fabiola Atzeni8, Roberto Caporali9, Marco Sebastiani10, Roberta Ramonda11, Serena Bugatti12, Elisa Gremese13, Maria Sole Chimenti14, Bruno Frediani15, Maurizio Rossini16, Angelo Semeraro17, Leonardo Santo18, Gianfranco Ferraccioli19, Giovanni Lapadula20, Fabrizio Conti1. | 1Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari, Sapienza Università di Roma; 2Dipartimento di Medicina di Precisione e Rigenerativa e Area Jonica, Università degli Studi Aldo Moro, Bari; 3ASST Spedali Civili di Brescia, Unità di Reumatologia ed Immunologia Clinica, Brescia; 4Dipartimento di Scienze Mediche e Sanità Pubblica, Università degli Studi di Cagliari; 5A.O.U. Policlinico S. Marco, UOS Reumatologia, Catania; 6Dipartimento di Scienze Mediche, Università di Ferrara; 7Unità di Reumatologia, Dipartimento di Medicina Specialistica, Università di Foggia; 8Dipartimento di Medicina Interna e Terapia Medica, UOC di Reumatologia, Università di Messina; 9Dipartimento di Scienze Cliniche e di Comunità, Università di Milano; 10Dipartimento di Medicina e Chirurgia, Università di Parma; 11Unità di Reumatologia, Dipartimento di Medicina, Università di Padova; 12Dipartimento di Medicina Interna e Terapia Medica, Università di Pavia, ; 13IRCCS Istituto Clinico Humanitas, Dipartimento di Scienze Biomediche, Milano; 14Dipartimento di Medicina dei Sistemi, Università degli Studi di Roma-Tor Vergata, ; 15Dipartimento di Medicina Clinica e Scienze Immunologiche, Università di Siena; 16Dipartimento di Medicina, Università di Verona; 17Presidio Ospedaliero Valle d'Itria, Unità Operativa di Reumatologia, Martina Franca; 18Presidio Ospedaliero "Mons. Dimiccoli", Unità Operativa Semplice di Reumatologia, Barletta; 19Gruppo Italiano di Studio sulla Early Arthritis, GISEA, Roma; 20Gruppo Italiano di Studio sulla early Arthritis, GISEA, Bari, Italy.
286 -
PO:07:101 | Efficacy and safety of methotrexate in a cohort of patients affected by early-onset rheumatoid arthritis: a monocentric real-life study Carlo Cauli1, Martina Favretti2, Giulio Dolcini2, Vincenzo Ferraro1, Cristina Iannuccelli3, Fabrizio Conti1, Manuela Di Franco1 | 1UOC Reumatologia, Dipartimento di scienze cliniche internistiche anestesiologiche e cardiovascolari, Sapienza, Roma; 2Dipartimento di Medicina Molecolare, La Sapienza, Roma; 3UOC Reumatologia, AOU Policlinico Umberto I, La Sapienza, Roma, Italy
246 -
CO:01:1 | Efficacy and safety of rituximab across the four phenotypes of IgG4-related disease: a European multi-center cohort study of 115 patients Marco Lanzillotta1, Jens Vikse2, Elisabetta Goni3, Veronica Batani1, Jasmin Mahajne1, Lorenzo Dagna1, Emanuel Della Torre1. | 1Unit of Immunology, Rheumatology, Allergy, and Rare Disease, IRCCS Ospedale San Raffaele, Milano, Italy; 2Department of Rheumatology, Stavanger University Hospital, Norway; 3Department of Medicine II, University Hospital, Ludwig Maximilian University, Munich, Germany
449 -
PO:33:203 | Efficacy and safety of rituximab in eosinophilic fasciitis: report of three cases and systematic literature review Andrea Benini1, Beatrice Moccaldi1, Marco Binda1, Anna Cuberli1, Mariangela Favaro1, Andrea Doria1, Elisabetta Zanatta1 | 1UOC Reumatologia, Azienda Ospedale, Università di Padova, Italy
352 -
PO:17:255 | Efficacy and safety of voclosporin in the management of lupus nephritis: a case series Alessandra Oliva1, Elisabetta Chessa2, Marta Paola Pireddu1, Marianna Salis1, Giulia Rizzo1, Fabio Congiu1, Elena Ragusa1, Antonello Pani3|4, Alberto Cauli1|2, Nicola Lepori3|4, Matteo Piga1|2 | 1UOC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università degli Studi di Cagliari; 2UOC Reumatologia, AOU Cagliari; 3SC Nefrologia e Dialisi, Università degli Studi di Cagliari; 4SC Nefrologia e Dialisi, Azienda Ospedaliera Brotzu, Cagliari, Italy
241 -
PO:10:149 | Efficacy of anifrolumab in a case of systemic lupus erythematosus with pulmonary involvement Fabio Brandolino1, Giulia Pazzola1, Luca Ronzoni3, Andreina Teresa Manfredi1|2, Carlo Salvarani1|2 | 1SC Reumatologia, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia; 2Università di Modena e Reggio Emilia, Scuola di specializzazione in Reumatologia, Modena; 3SC Malattie dell'Apparato Respiratorio, IRCCS Arcispedale Santa Maria Nuova, AUSL Reggio Emilia, Italy
361 -
PO:28:127 | Efficacy of b/ts-DMARDS therapy on depressive and anxiety symptoms in patients with chronic inflammatory joint diseases: preliminary results of a prospective study Nikita Pecani1, Christian D'Elia1, Francesca Bartoli1, Sabrina Aliberti1, Francesco Rotella2, Arianna Ida Altomare2, Francesco Vinci2, Lorenzo Cortoni2, Davide Benedetti3, Camilla Ferrari4, Gemma Lepri1, Silvia Bellando Randone1, Serena Guiducci1 | 1SOD Reumatologia, Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi di Firenze; 2Unità di Psichiatria, Dipartimento di Scienze della Salute, Università degli Studi di Firenze; 3Dipartimento Salute Mentale, USL Umbria, Città di Castello (PG); 4Scuola di Scienze della Salute Umana - Università degli Studi di Firenze, Italy
247 -
PO:37:270 | Efficacy of iloprost as a therapy for skin ulcers in cryofibrinogenemia and cryoglobulinemia: a complex case in a fragile patient Luca Keller Sarmiento1, Amelia Spinella2, Marco De Pinto2, Giorgia Roveta1, Dilia Giuggioli1|2. | 1Università degli Studi di Modena e Reggio Emilia, Modena, Italy; 2Unità di Reumatologia del Policlinico di Modena, Modena, Italy.
227 -
PO:16:233 | Efficacy of voclosporin on nephritis in patients with variable gain of function of TLR7 affected by lupus: clinical case Veronica Spedicato1, Laura Coladonato1, Marco Fornaro1, Marlea Lavista1, Daniele Sabella1, Marco Capodiferro1, Maria Morrone1, Crescenzio Scioscia1, Giuseppe Lopalco1, Florenzo Iannone1 | 1Unit of Rheumathology, Department of Precision and Regenerative Medicina, Area JonicaJ, University of Bari, Italy
245 -
CO:07:5 | Enhanced fibroblast signatures in females with early rheumatoid arthritis highlights a potential basis for poorer treatment outcomes Benedetta Monosi1, James Perera2, Alessandra Nerviani2|3, Maria Sole Chimenti1, Felice Rivellese2|3, Costantino Pitzalis2|3|4. | 1Rheumatology, Allergology and Clinical Immunology, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy; 2Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, London, UK; 3Barts Health NHS Trust and Barts Biomedical Research Centre, National Institute for Health and Care Research, London, UK; 4Department of Biomedical Sciences Humanitas University and IRCCS Humanitas Research Hospital, Milano, Italy
3897 -
S14:5 | Erosive hand osteoarthritis: premenopausal onset and more severe disease progression Marta Favero1, Giacomo Cozzi1, Clarissa Benvoluti1, Laura Scagnellato1, Gianluca Poncina1, Stefano Rizzetto1, Mariagrazia Lorenzin1, Roberta Ramonda1 | 1UOC di Reumatologia, Dipartimento di Medicina-DIMED, Università di Padova, Italy
282 -
CO:09:4 | Erosive hand osteoarthritis: the impact of comorbidities in the context of joint disease Sara Bindoli1, Clarissa Benvoluti1, Giacomo Cozzi1, Marta Favero1, Mariagrazia Lorenzin1, Andrea Doria1, Paolo Sfriso1, Roberta Ramonda1. | 1UOC Reumatologia, Dipartimento di Medicina , Università degli studi di Padova, Italy
299